Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites across US states and international locations (e.g., Arizona, California, Ohio, Ontario, Aichi-ken, Tokyo, etc.). The former state- and country-specific location subsections were replaced.
    Difference
    2%
    Check dated 2025-12-24T02:27:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no substantive content changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:43:35.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill disclaimer indicating that publications are automatically filled from PubMed and may not pertain to the study. Updated the revision label to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:16:35.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed from the page. The study details and navigation remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T06:11:56.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    New date labels such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-03, 2025-10-31) were added to the Study Details page, reflecting update history and not altering study data or eligibility; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-10T02:08:37.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    Added publication reference: Muro K et al. Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers, ESMO Open. 2025;10(11):105806 (doi:10.1016/j.esmoop.2025.105806). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:50:08.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.